Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval of Biogen and Sage Therapeutics' depression pill for a smaller-than-expected patient cohort has fueled concerns over its growth prospects, analysts said on Monday. The U.S....
The U.S. drug regulator's approval of Biogen and Sage Therapeutics' first-of-its-kind postpartum depression pill is unlikely to allay the drugmakers' growth concerns, analysts said on Monday. ...
The FDA approved the pill zuranolone, developed by Sage and Biogen, for postpartum depression but declined to approve it for major depressive disorder.
Shares of Sage Therapeutics slumped to a record low on Monday after the U.S. health regulator approved the company and partner Biogen's pill for postpartum depression, but rejected it as a...